コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します

1 We developed a 16-item model.

2 We developed a cell delivery strategy based on a supramolecul

3 We developed a derivation model to determine the relative inf

4 We developed a fluctuation test based on reversion to fluores

5 We developed a genetic toolkit to study MT dynamics and funct

6 We developed a method to directly capture lipid antigens with

7 We developed a multiscale model of fibrinolysis that includes

8 We developed a new MALS methodology that has overcome the lon

9 We developed a new method (called REPPS) for incorporating ex

10 We developed a new multivariable linear model for GFR using s

11 We developed a new scoring system for calculating morbidity a

12 We developed a novel analytical framework for mapping and tes

13 We developed a novel method to compute gene-level P-values (f

14 We developed a novel methodology for burden estimation and pr

15 We developed a panel of tunable expression platforms for the

16 We developed a platform for microfluidics-assisted cell scree

17 We developed a transmission-dynamic model on a dynamic networ

18 We developed a two-alternative forced-choice task in an autom

21 ments in the statistical analysis of high-dimensional data, we developed a new Debiased Sparse Partial Correlation algori

22 change data sets that explore pH and particle size effects, we developed a stochastic simulation that exactly mimics thes

25 o study the role of neutrophils in LPS-induced endotoxemia, we developed a new mouse model, PMN(DTR) mice, in which injec

26 To quantify the substructure of FAs, we developed a clustering method based on expectation maximiz

30 loration of aquatic environments (surface and groundwater), we developed a technique for field continuous measurements of

36 g Km and kcat requires multiple steps of data manipulation, we developed a computational approach (bootstrapping) to prop

37 ts of increased CD39 in an in vivo cerebral ischemia model, we developed a transgenic mouse expressing human CD39 (hCD39)

38 ncy (UPI) increases severity of retinopathy of prematurity, we developed a composite rat model of UPI and oxygen-fluctuat

43 tigate the contribution of the TL to intrinsic termination, we developed a kinetic assay that distinguishes effects of TL

45 s are less representative of community exposure; therefore, we developed a novel spatial phytosampling methodology to stu

47 To model hydrostatic pressure-induced edema in vitro, we developed a method of applied pressure to the basolateral

48 e detection of N-chlorinated dipeptides in authentic water, we developed a high-performance liquid chromatography-tandem

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。